E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/19/2021 in the Prospect News Structured Products Daily.

New Issue: Citigroup prices $1.82 million of autocallable equity-linked notes on Moderna, Palantir

By Taylor Fox

New York, March 19 – Citigroup Global Markets Holdings Inc. priced $1.82 million of 21% autocallable equity-linked securities due March 14, 2022 tied to the common stocks of Moderna, Inc. and Palantir Technologies Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be guaranteed by Citigroup Inc.

Interest is payable monthly.

The notes will be automatically redeemed at par if both stocks close at or above their initial prices on any monthly autocall date after three months.

The payout at maturity will be par unless any stock finishes below its initial price and ever closes below its knock in level, 60% of its initial price, in which case investors will receive a fixed number of shares of the worst performer equal to its equity ratio divided by the initial price or, at the issuer’s option, the cash equivalent.

Citigroup Global Markets Inc. is the underwriter.

Issuer:Citigroup Global Markets Holdings Inc.
Guarantor:Citigroup Inc.
Issue:Autocallable equity-linked securities
Underlying stocks:Moderna, Inc. and Palantir Technologies Inc.
Amount:$1,817,000
Maturity:March 14, 2022
Coupon:21% per year, payable monthly
Price:Par
Payout at maturity:Par unless any stock finishes below its initial price and ever closes below its knock in level, 60% of its initial price, in which case full exposure to losses of worst performer, payable in either shares or cash
Call:At par if each stocks closes at or above initial price on any monthly autocall date after three months
Initial prices:$130.87 for Moderna and $24.26 for Palantir
Downside thresholds:$78.522 for Moderna and $14.556 for Palantir, 50% of initial prices
Equity ratios:7.64117 for Moderna and 41.22012 for Palantir
Pricing date:March 9
Settlement date:March 12
Underwriter:Citigroup Global Markets Inc.
Fees:2.875%
Cusip:17328NLZ9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.